Salem Investment Counselors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,075
| Closed | -$168K | – | 944 |
|
|
2020
Q4 | $168K | Hold |
1,075
| – | – | 0.01% | 287 |
|
|
2020
Q3 | $123K | Hold |
1,075
| – | – | 0.01% | 285 |
|
|
2020
Q2 | $121K | Buy |
1,075
+1,050
| +4,200% | +$118K | 0.01% | 282 |
|
|
2020
Q1 | $2K | Sell |
25
-165
| -87% | -$13.2K | ﹤0.01% | 638 |
|
|
2019
Q4 | $21K | Sell |
190
-36,950
| -99% | -$4.08M | ﹤0.01% | 487 |
|
|
2019
Q3 | $3.64M | Sell |
37,140
-810
| -2% | -$79.3K | 0.33% | 69 |
|
|
2019
Q2 | $4.97M | Buy |
37,950
+1,305
| +4% | +$171K | 0.46% | 55 |
|
|
2019
Q1 | $5.09M | Sell |
36,645
-2,345
| -6% | -$326K | 0.52% | 49 |
|
|
2018
Q4 | $3.8M | Buy |
38,990
+2,345
| +6% | +$228K | 0.48% | 51 |
|
|
2018
Q3 | $5.09M | Buy |
36,645
+3,835
| +12% | +$533K | 0.52% | 49 |
|
|
2018
Q2 | $4.07M | Buy |
32,810
+905
| +3% | +$112K | 0.37% | 57 |
|
|
2018
Q1 | $3.45M | Buy |
31,905
+31,825
| +39,781% | +$3.44M | 0.39% | 65 |
|
|
2017
Q4 | $10K | Sell |
80
-131
| -62% | -$16.4K | ﹤0.01% | 460 |
|
|
2017
Q3 | $30K | Hold |
211
| – | – | ﹤0.01% | 360 |
|
|
2017
Q2 | $26K | Buy |
+211
| New | +$26K | ﹤0.01% | 381 |
|